Photodynamic therapy;Traitement photodynamique

Journal Francais d'Ophtalmologie

Volumn 25, Issue 7, 2002, Pages 753-755

  Soubrane, G ^a   Kuhn, D ^a   Oubraham, H ^a   Coscas, G ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Exudative age related macular degeneration; Photodynamic therapy; Randomized studies; Retrofoveal choroidal neovascularization

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

CLINICAL TRIAL; DISEASE COURSE; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG EFFICACY; DRUG EXTRAVASATION; DRUG INDUCED DISEASE; EVALUATION; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; RETREATMENT; SHORT SURVEY; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGING; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR DEGENERATION; NEOVASCULARIZATION, PATHOLOGIC; PHOTOCHEMOTHERAPY;

EID: 0036764167     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, et coll.: Photodynamic therapy with Verteporfin for choroidal neovascularization caused by age-related macular degeneration. Results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol, 1999;117:1161-73.
2. Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, et coll. Photodynamic therapy with Verteporfin for choroidal neovascularization caused by age-related macular degeneration. Results of retreatments in a phase 1 and 2 study. Arch Ophthalmol, 1999;117:1177-87.
3. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group: Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with Verteporfin. One-year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol, 1999;117:1329-45.
4. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group: Verteporfin (Visudyne♂) Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration. Impact of Lesion Component on One-year Visual Outcomes - TAP Report #2. January 2000.
5. Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW. Effects of photodynamic therapy using Verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci, 1999;40:2322-31.
6. Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology, 1999;106:1915-23.